Chidamide (also named Tucidinostat) is a histone deacetylase (HDAC) inhibitor that is used to treat various…
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab sold under the brand name…
Linperlisib, a next-generation PI3Kδ-selective oral inhibitor, received marketing approval in China in 2022 for treatment of…
Zuberitamab is an innovative anti-CD20 monoclonal antibody injection. Zuberitamab is a biosimilar of rituximab, a monoclonal…
Golidocitinib (DZD4205) is currently the first and only Janus kinase 1 (JAK1) selective inhibitor being evaluated…
About Pirtobrutinib Pirtobrutinib is an inhibits B cell lymphocyte proliferation and survival by binding and inhibiting Bruton's tyrosine…
Zimberelimab is an anti-programmed cell death protein-1 (PD-1) monoclonal antibody being developed by Gloria Biosciences, Arcus…
Gilteritinib is a small molecule part of the FLT3 tyrosine kinase inhibitors that presented a greater…